EIP
BIO icon

Epoch Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Epoch Investment Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,243
Closed -$12.3M – 277
2019
Q2 		$12.3M Sell
39,243
-24,017
-38% -$7.19M 0.06% 187
2019
Q1 		$19.3M Sell
63,260
-767
-1% -$207K 0.08% 161
2018
Q4 		$14.9M Sell
64,027
-6,610
-9% -$1.77M 0.07% 193
2018
Q3 		$22.1M Sell
70,637
-31,270
-31% -$9.71M 0.08% 173
2018
Q2 		$29.4M Sell
101,907
-74,972
-42% -$20.7M 0.09% 153
2018
Q1 		$44.2M Sell
176,879
-20,691
-10% -$5.27M 0.16% 118
2017
Q4 		$47.2M Sell
197,570
-52,334
-21% -$12.7M 0.16% 116
2017
Q3 		$55.5M Buy
249,904
+24,420
+11% +$5.5M 0.19% 109
2017
Q2 		$51M Sell
225,484
-9,865
-4% -$2.15M 0.17% 117
2017
Q1 		$46.9M Sell
235,349
-12,259
-5% -$2.36M 0.16% 129
2016
Q4 		$45.1M Sell
247,608
-21,875
-8% -$3.73M 0.17% 111
2016
Q3 		$44.1M Sell
269,483
-7,785
-3% -$1.18M 0.16% 118
2016
Q2 		$39.7M Sell
277,268
-4,837
-2% -$690K 0.15% 122
2016
Q1 		$38.6M Buy
282,105
+12,295
+5% +$1.61M 0.15% 119
2015
Q4 		$37.4M Buy
269,810
+12,984
+5% +$1.8M 0.15% 114
2015
Q3 		$34.5M Buy
256,826
+74,407
+41% +$10.7M 0.13% 120
2015
Q2 		$27.5M Sell
182,419
-6,209
-3% -$888K 0.1% 150
2015
Q1 		$25.5M Buy
188,628
+5,075
+3% +$629K 0.1% 151
2014
Q4 		$22.1M Sell
183,553
-4,427
-2% -$510K 0.08% 156
2014
Q3 		$21.3M Buy
+187,980
New +$22.3M 0.08% 156

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Epoch Investment Partners's BIO Position: Q3 2019 in Review

Epoch Investment Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2019, closing a stake of 39,243 shares — an estimated $12.3M sold.

Epoch Investment Partners first reported a position in BIO in Q3 2014 and held it in 20 quarters. The position peaked at $55.5M in Q3 2017. 355 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

  • Epoch Investment Partners reported no remaining Bio-Rad Laboratories Class A position as of Q3 2019 after selling out during the quarter.
  • Epoch Investment Partners sold 39,243 Bio-Rad Laboratories Class A shares in Q3 2019, an estimated $12.3M.
  • Epoch Investment Partners first reported a position in Bio-Rad Laboratories Class A in Q3 2014 and held it in 20 quarters.
  • Epoch Investment Partners's Bio-Rad Laboratories Class A position peaked at $55.5M in Q3 2017.
  • 355 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on Epoch Investment Partners's 13F filing for Q3 2019, filed 13 Nov 2019.